Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing HaemodialysisAn Open-Label, Single-Centre Study

被引:0
|
作者
Egbert G. Schulz
Shadfar Bahri
Volker Schettler
Aron-Frederik Popov
Matthias Hermann
机构
[1] Centre of Nephrology Goettingen,Department of Thoracic Cardiovascular Surgery
[2] University of Goettingen,Department of Cardiology
[3] University Hospital Zurich,undefined
来源
关键词
Candesartan; Aliskiren; Endstage Renal Failure; Candesartan Cilexetil; Anuric Patient;
D O I
暂无
中图分类号
学科分类号
摘要
Background and Objective: In patients with endstage renal failure (ERF), activation of the renin-angiotensin-aldosterone system plays an important role in the onset and maintenance of arterial hypertension. This study aimed to elucidate the antihypertensive effect, pharmacokinetics and safety of candesartan cilexetil in patients with ERF undergoing haemodialysis.
引用
收藏
页码:713 / 719
页数:6
相关论文
共 50 条
  • [1] Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing Haemodialysis An Open-Label, Single-Centre Study
    Schulz, Egbert G.
    Bahri, Shadfar
    Schettler, Volker
    Popov, Aron-Frederik
    Hermann, Matthias
    CLINICAL DRUG INVESTIGATION, 2009, 29 (11) : 713 - 719
  • [2] IncobotulinumtoxinA for hypersalivation in patients with amyotrophic lateral sclerosis: an open-label single-centre study
    Lejla Paracka
    Katja Kollewe
    Martin Klietz
    Susanne Petri
    Dirk Dressler
    Journal of Neural Transmission, 2019, 126 : 1341 - 1345
  • [3] IncobotulinumtoxinA for hypersalivation in patients with amyotrophic lateral sclerosis: an open-label single-centre study
    Paracka, Lejla
    Kollewe, Katja
    Klietz, Martin
    Petri, Susanne
    Dressler, Dirk
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (10) : 1341 - 1345
  • [4] Pharmacokinetics and Pharmacodynamics of Cinacalcet in Hepatic ImpairmentPhase I, Open-Label, Parallel-Group, Single-Dose, Single-Centre Study
    Desmond Padhi
    Robert Z. Harris
    Margaret Salfi
    Robert J. Noveck
    John T. Sullivan
    Clinical Drug Investigation, 2008, 28 : 635 - 643
  • [5] Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran EtexilateAn Open-Label, Parallel-Group, Single-Centre Study
    Joachim Stangier
    Karin Rathgen
    Hildegard Stähle
    Dago Mazur
    Clinical Pharmacokinetics, 2010, 49 : 259 - 268
  • [6] Metabolic and haemostatic effects of estradiol valeratedienogest, a novel oral contraceptive: A randomized, open-label, single-centre study
    Junge W.
    Mellinger U.
    Parke S.
    Serrani M.
    Clinical Drug Investigation, 2011, 31 (8) : 573 - 584
  • [7] Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate An Open-Label, Parallel-Group, Single-Centre Study
    Stangier, Joachim
    Rathgen, Karin
    Stahle, Hildegard
    Mazur, Dago
    CLINICAL PHARMACOKINETICS, 2010, 49 (04) : 259 - 268
  • [8] Irsogladine is Effective for Recurrent Oral Ulcers in Patients with Behcet's Disease An Open-Label, Single-Centre Study
    Nanke, Yuki
    Kamatani, Naoyuki
    Okamoto, Toshihiro
    Ogiuchi, Hideki
    Kotake, Shigeru
    DRUGS IN R&D, 2008, 9 (06) : 455 - 459
  • [9] Pharmacokinetics and bioequivalence study of candesartan cilexetil tablet in Chinese volunteers under fasting condition: an open-label, randomizedsequence, 2-period crossover study
    Han, Meiling
    He, Yingxia
    Liang, Jun
    Yao, Fang
    Lu, Pan
    Yan, Hegui
    Wang, Jie
    Xie, Yafang
    Li, Xiuwen
    Liu, Qiangwei
    Liu, Yang
    Yuan, Baodong
    Zhou, Ming
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2024, 32 (02) : 107 - 114
  • [10] Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial
    Ahmed, Asra
    Merrill, Samuel A.
    Alsawah, Fares
    Bockenstedt, Paula
    Campagnaro, Erica
    Devata, Sumana
    Gitlin, Scott D.
    Kaminski, Mark
    Cusick, Alice
    Phillips, Tycel
    Sood, Suman
    Talpaz, Moshe
    Quiery, Albert
    Boonstra, Philip S.
    Wilcox, Ryan A.
    LANCET HAEMATOLOGY, 2019, 6 (12): : E630 - E637